Newsroom

Sorted by: Latest

-

Cyted Health to Present U.S. Clinical Validation Data for the EndoSign® Barrett’s Esophagus Test in Late-Breaking Plenary Session at ACG 2026

NASHVILLE, Tenn.--(BUSINESS WIRE)--Cyted Health: WHAT Cyted Health will present clinical validation data from DETECT-ME, a prospective, 18-site U.S. study of the EndoSign® Barrett’s esophagus (BE) Test, as a late-breaking abstract in a plenary session at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting. Session: Plenary Session 4A: Esophagus / Practice Management Presentation #64: “A Prospective, Multicenter Cohort Study of a Novel Methylation Biomarker Panel Using...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 Rotork plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 12.10.2026 FPX. IE00BYTH6238  250,002.00 USD  16,615,823.27   66.463  ...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 12.10.2026 FKU IE00B8X9NZ57  181,700.00 GBP   8,118,857.89   44.683  ...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 12.10.2026 FGBL.LN IE00BYTH6121  464,196.00 USD  46,068,460.28   99.244  ...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 Mitie Group plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

Emera Declares Quarterly Dividends

HALIFAX, Nova Scotia--(BUSINESS WIRE)--On October 13, 2026, the Board of Directors of Emera Inc. (TSX/NYSE: EMA) declared quarterly dividends on its common shares and First Preferred Shares, each of which is payable on and after November 13, 2026 to the applicable shareholders of record at the close of business on October 30, 2026, as follows: $0.74 per common share; $0.3094 per Series A First Preferred Share; $0.40213 per Series C First Preferred Share; $0.28125 per Series E First Preferred Sh...
-

State Street Elects Alexander Vollert to Its Board of Directors

BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) today announced the election of Alexander Vollert to its Board of Directors. Vollert brings more than two decades of leadership experience across global financial services, with deep expertise in technology, operations, and large-scale transformation. Most recently, Vollert served as Group Chief Operating Officer of AXA and Chief Executive Officer of AXA Group Operations, where he led approximately 10,000 employees across 18 countrie...